BIOMAT Database Logo BIOMAT Database Logo

Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man. 1983

Y Mizushima, and A Yanagawa, and K Hoshi

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008863 Microspheres Small uniformly-sized spherical particles, of micrometer dimensions, frequently labeled with radioisotopes or various reagents acting as tags or markers. Latex Beads,Latex Particles,Latex Spheres,Microbeads,Bead, Latex,Beads, Latex,Latex Bead,Latex Particle,Latex Sphere,Microbead,Microsphere,Particle, Latex,Particles, Latex,Sphere, Latex,Spheres, Latex
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1

Related Publications

Y Mizushima, and A Yanagawa, and K Hoshi
Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres.
October 2000, The Journal of rheumatology,
Y Mizushima, and A Yanagawa, and K Hoshi
Application of lipid microspheres containing prostaglandin E1 ointment to peripheral ischemic ulcers.
January 1997, Dermatology (Basel, Switzerland),
Y Mizushima, and A Yanagawa, and K Hoshi
Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.
September 1999, Japanese journal of pharmacology,
Y Mizushima, and A Yanagawa, and K Hoshi
[Protective effects of LipoPGE1, prostaglandin E1 incorporated in lipid microspheres, against liver injury caused by ischemia-reperfusion].
February 1995, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Y Mizushima, and A Yanagawa, and K Hoshi
Prostaglandin E1 therapy for peripheral vascular disease is better than placebo.
April 1982, Clinical physiology (Oxford, England),
Y Mizushima, and A Yanagawa, and K Hoshi
Lipo-PGE1, prostaglandin E1 incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion.
January 1996, Free radical biology & medicine,
Y Mizushima, and A Yanagawa, and K Hoshi
Prostaglandin E1 in obstructive peripheral vascular disease.
January 1983, The Mount Sinai journal of medicine, New York,
Y Mizushima, and A Yanagawa, and K Hoshi
Intravenous prostaglandin E1 in severe peripheral vascular disease.
October 1976, Lancet (London, England),
Y Mizushima, and A Yanagawa, and K Hoshi
[Treatment of the peripheral vascular diseases with prostaglandin].
August 1994, Nihon rinsho. Japanese journal of clinical medicine,
Y Mizushima, and A Yanagawa, and K Hoshi
Inhibitory effects of alprostadil (prostaglandin E1) incorporated in lipid microspheres of soybean oil on intimal hyperplasia following balloon injury in rabbits.
January 2002, Arzneimittel-Forschung,
Copied contents to your clipboard!